Home  |   About  |   Theory  |   Tutorials  |   FAQ  |   Bahar Lab  |   Statistics

Viewer control panel                    

Network of interactions between drugs (red spheres) and targets (blue spheres) is displayed above.
The red lines are used for the predicted interactions and the thickness of edges indicate the confidence score of predictions.

Results:

Download Network (json)

Download results

Data source: DrugBank-all; Query type: target; # of requested predictions: 20; Secondary interactions: no
Input target 1: P00740

No.	Gene	UniProt ID	Protein Name	Pathway	PDB
1	F9	P00740	Coagulation factor IX	hsa04610	1CFH; 1CFI; 1EDM; 1IXA; 1MGX; 1NL0; 1RFN; 2WPH; 2WPI; 2WPJ; 2WPK; 2WPL; 2WPM; 3KCG; 3LC3; 3LC5; 4WM0; 4WMA; 4WMB; 4WMI; 4WMK; 4WN2; 4WNH; 4YZU; 4Z0K; 4ZAE; 5EGM

No.	Group	Type	Drug ID	Drug Name	SMILES ⇨ TargetHunter	Image
1	Approved; Investigational	BiotechDrug	DB13150	Coagulation factor VII human	NA
2	Approved	BiotechDrug	DB13999	Moroctocog alfa	NA
3	Approved; Investigational	BiotechDrug	DB09109	Turoctocog alfa	NA
4	Approved; Investigational	BiotechDrug	DB13923	Emicizumab	NA
5	Approved; Investigational	BiotechDrug	DB13998	Lonoctocog alfa	NA
6	Approved; Nutraceutical	SmallMoleculeDrug	DB00170	Menadione	CC1=CC(=O)C2=CC=CC=C2C1=O
7	Approved; Investigational	BiotechDrug	DB09329	Antihemophilic Factor (Recombinant), PEGylated	NA
8	Investigational	SmallMoleculeDrug	DB05131	TTP889	NA
9	Approved	BiotechDrug	DB13192	Antihemophilic factor human	NA
10	Approved; Investigational	BiotechDrug	DB00025	Antihemophilic factor, human recombinant	NA
11	Approved	SmallMoleculeDrug	DB09332	Kappadione	[Na+].[Na+].[Na+].[Na+].CC1=C(OP([O-])([O-])=O)C2=CC=CC=C2C(OP([O-])([O-])=O)=C1

No.	Group	Type	Drug ID	Drug Name	SMILES ⇨ TargetHunter	Image	Confidence score
1	Investigational	BiotechDrug	DB06245	Lanoteplase	NA		54.2%
2	Approved	BiotechDrug	DB13149	Protein S human	NA		51.5%
3	Approved	BiotechDrug	DB00036	Coagulation factor VIIa Recombinant Human	NA		48.5%
4	Approved	BiotechDrug	DB13152	Coagulation Factor IX Human	NA		43.7%
5	Approved; Investigational	SmallMoleculeDrug	DB00464	Sodium Tetradecyl Sulfate	[Na+].CCCCC(CC)CCC(CC(C)C)OS([O-])(=O)=O		39.7%
6	Approved; Investigational	BiotechDrug	DB00100	Coagulation Factor IX (Recombinant)	NA		38.1%
7	Experimental	SmallMoleculeDrug	DB03847	Gamma-Carboxy-Glutamic Acid	N[C@@H](CC(C(O)=O)C(O)=O)C(O)=O		37.9%
8	Experimental	SmallMoleculeDrug	DB07277	2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE	[H][C@@](C)(N1CC[C@]([H])(NS(=O)(=O)CCC2=CC=C(Cl)S2)C1=O)C(=O)N1CCOCC1		37.6%
9	Approved; Investigational	BiotechDrug	DB13933	Nonacog beta pegol	NA		35.3%
10	Approved	BiotechDrug	DB00031	Tenecteplase	NA		34.7%
11	Approved; Investigational	SmallMoleculeDrug	DB01593	Zinc	[Zn]		34.4%
12	Approved; Investigational	BiotechDrug	DB13151	Anti-inhibitor coagulant complex	NA		33.4%
13	Experimental	SmallMoleculeDrug	DB08488	4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE	ClC1=CC=C(S1)\C=C\S(=O)(=O)N1CCN(CC2=CC3=C(N2)C=CN=C3)C(=O)C1		32.8%
14	Approved	SmallMoleculeDrug	DB09075	Edoxaban	CN(C)C(=O)[C@H]1CC[C@H](NC(=O)C(=O)NC2=NC=C(Cl)C=C2)[C@@H](C1)NC(=O)C1=NC2=C(CN(C)CC2)S1		32.6%
15	Experimental	SmallMoleculeDrug	DB08174	5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE	[H][C@]1(CCC[C@]1([H])NC(=O)C1=CC=C(C=C1)N1C=CC=CC1=O)NC(=O)C1=CC=C(Cl)S1		32.5%
16	Experimental	SmallMoleculeDrug	DB07261	THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE	[H][C@@]1(CCN(CC2=CC3=C(C=CN=C3N)C=C2)C1=O)NS(=O)(=O)C1=CC2=C(S1)C=CC=N2		32.4%
17	Experimental	SmallMoleculeDrug	DB08143	5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE	[H][C@]1(F)CN(CC(=O)NC2=CC=C(C=C2F)N2C=CC=CC2=O)C[C@]1([H])NC(=O)C1=CC=C(Cl)S1		32.1%
18	Experimental	SmallMoleculeDrug	DB07843	5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE	[H][C@@](C)(N1CC[C@]([H])(NS(=O)(=O)C2=CC3=C(S2)C=CC(Cl)=C3)C1=O)C(=O)N1CCOCC1		32.0%
19	Approved; Investigational; Withdrawn	BiotechDrug	DB00055	Drotrecogin alfa	NA		31.7%
20	Experimental	SmallMoleculeDrug	DB07629	N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE	[H][C@@]1(CCCC[C@@]1([H])NC(=O)C1=NC2=C(CN(C)CC2)S1)NC(=O)C1=CC2=C(N1)C=CC(Cl)=C2		31.5%